Nida Imtiaz | Developmental Biology | Best Researcher Award

Posted on by Pencis

Dr. Nida Imtiaz | Developmental Biology | Best Researcher Award

Ningbo University | China

Author Profile

Scopus

Google Scholar

👩‍🎓 NIDA IMTIAZ: A DEDICATED RESEARCHER IN AQUACULTURE AND MARINE SCIENCES

🎓 EARLY ACADEMIC PURSUITS

Nida Imtiaz embarked on her academic journey with a strong foundation in biological sciences. She pursued her education in Pakistan, obtaining:

  • Ph.D. (Dec. 2024) in Aquaculture from Ningbo University, China.
  • M.Phil. in Animal Genomics and Biotechnology from the PARC Institute of Advanced Studies in Agriculture, National Agricultural Research Centre (NARC), Islamabad, Pakistan.
  • M.Sc. in Zoology from PMAS Arid Agriculture University, Rawalpindi, Pakistan.
  • B.Sc. from the University of the Punjab, Lahore, Pakistan.
  • Intermediate (Pre-Medical) and Matriculation from BISE, Rawalpindi, Pakistan.

🌍 PROFESSIONAL ENDEAVORS

Nida Imtiaz has accumulated extensive research and professional experience in the fields of aquaculture, fisheries, and biological sciences. Her significant contributions include:

  • Internship at a reputed feed mill (Aug 2013 - Nov 2014).
  • Research Assistant in Animal Nutrition Laboratories at NARC Islamabad (Jan 2016 - Feb 2017).
  • Assistant Scientific Officer in the Aquaculture and Fisheries Program at NARC Islamabad (April 2017 - June 2018).
  • Extensive research on crab culture and embryogenesis, particularly with Scylla paramamosain and Portunus trituberculatus.

📝 CONTRIBUTIONS AND RESEARCH FOCUS ON DEVELOPMENTAL BIOLOGY

Her research primarily focuses on aquaculture, marine sciences, and biological sciences, with an emphasis on:

  • Embryonic development in mud crabs (Scylla paramamosian), analyzing morphological, physiological, and molecular dynamics.
  • Impact of noise on stress response in Portunus trituberculatus in land-based monoculture systems.
  • Comparative analysis of amino acid and fatty acid profiles in different Scylla species to unveil their nutritional benefits.
  • Aflatoxin contamination in animal feed and milk in Pakistan.
  • Aqua feed production for commercially important fish species.
  • Study of Parkinson’s disease prevalence and fungal skin infestations in human populations.

💪 IMPACT AND INFLUENCE

Nida Imtiaz has made substantial contributions to aquaculture research, particularly in the areas of:

  • Crustacean embryology and nutritional analysis, influencing sustainable aquaculture practices.
  • Enhancing feed quality and safety in Pakistan’s livestock industry.
  • Promoting bioinformatics and statistical modeling in fisheries and marine sciences.
  • Contributing to scientific knowledge through international conferences, seminars, and research collaborations.

🎯 ACADEMIC CITATIONS AND PUBLICATIONS

Her research findings are currently under submission in reputed scientific journals:

  • "Comparative transcriptome profiles across distinct developmental stages in Scylla paramamosain embryos" (Comparative Biochemistry and Physiology Part-D, 2024).
  • "Mutation Analysis of tp53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan." (International Journal of Biosciences).

🏆 AWARDS AND RECOGNITIONS

Nida Imtiaz has received multiple prestigious awards, including:

  • Zhuo Chuang Scholarship (2023) at Ningbo University, Zhejiang, China.
  • Chinese Government Scholarship (2019-onwards) for her Ph.D. studies at Ningbo University.

📚 CONFERENCES AND SEMINARS

She has actively participated in academic discussions and knowledge-sharing platforms:

  • 4th International Conference on Biological and Computer Sciences at Capital University of Science and Technology, Islamabad.
  • National Policy Dialogue on Aflatoxin Contamination of Milk in Pakistan.
  • Mountain-Specific Innovative Solutions Conference (2017) at NARC, Islamabad.
  • 12th Chinese Symposium on Crustacean Aquaculture (2023) in Ningbo, China.

📝 FUTURE CONTRIBUTIONS AND LEGACY

As a dedicated scientist, Nida Imtiaz aims to:

  • Advance research in marine and aquaculture sciences, particularly in sustainable fisheries.
  • Develop innovative solutions for aqua feed production to enhance food security.
  • Contribute to bioinformatics and computational biology for better understanding of genetic mechanisms in marine species.
  • Mentor and train young researchers, fostering future experts in biological sciences.

📑NOTABLE PUBLICATIONS 

"Lipid dynamics during embryonic development of Scylla paramamosain: Insights from lipidomics" 

  • Authors: N., Imtiaz, Nida , Y., Jiang, Yaqi , Y., Yangfang, Ye , M., Changkao, Mu , Q., Wu, Qingyang
  • Journal: Aquaculture
  • Year: 2025

Leilei Wu | Lung Cancer | Best Researcher Award

Posted on by Pencis

Dr. Leilei Wu | Lung Cancer | Best Researcher Award

Zhejiang Cancer Hospital | China

Author Profile

Scopus

Orcid ID

📘 BIOGRAPHY OF DR. LEILEI WU

🎓 EARLY ACADEMIC PURSUITS

Dr. Leilei Wu laid the groundwork for his exceptional career by pursuing an M.D. and Ph.D., focusing his academic efforts on advancing knowledge in thoracic surgery. During his formative years, he displayed a strong dedication to understanding the complexities of lung cancer and esophageal cancer, particularly their diagnosis and treatment.

🏥 PROFESSIONAL ENDEAVORS

As a member of the Department of Thoracic Surgery at Zhejiang Cancer Hospital, Hangzhou, Dr. Wu has combined surgical expertise with groundbreaking research. He is actively involved in clinical and translational studies, making substantial contributions to advancing thoracic surgery techniques and treatment protocols for lung and esophageal cancer.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON LUNG CANCER

Dr. Wu's research focuses on innovative treatment strategies for thoracic malignancies. His contributions include:

  1. Exploring the synergy of AMG-510 with cisplatin for increased antitumor effects in KRAS G12C mutant lung adenocarcinoma.
  2. Studying the prognosis and risks of diabetes mellitus post-lung transplantation, offering critical insights into patient care.
  3. Investigating the compound Osalmid for its dual effects in inhibiting lung adenocarcinoma progression and enhancing EGFR-TKI therapy sensitivity.

🌍 IMPACT AND INFLUENCE

Dr. Wu's research has gained international recognition through prestigious conferences:

  • Poster Presentation: 31st European Conference on General Thoracic Surgery, Milano, Italy (2023)
    • “AMG-510 and Cisplatin Combination Increases Antitumor Effect in Lung Adenocarcinoma with KRAS G12C Mutation.”
  • Oral Presentation: 31st European Conference on General Thoracic Surgery, Milano, Italy (2023)
    • “Prognosis and Risk of Diabetes Mellitus in Patients After Lung Transplantation.”
  • Poster Presentation: IASLC World Conference on Lung Cancer, San Diego, USA (2024)
    • “Osalmid Inhibits Lung Adenocarcinoma Progression and Sensitizes to EGFR-TKIs: A Preclinical Study.”

📈 ACADEMIC CITES AND RECOGNITION

Dr. Wu's innovative work has garnered significant attention from peers, highlighting his commitment to excellence. His contributions to thoracic oncology are cited frequently, reflecting the relevance and influence of his research in the scientific community.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Wu aims to further transform thoracic oncology by:

  • Developing precision medicine techniques tailored to individual genetic profiles.
  • Refining minimally invasive surgical methods.
  • Mentoring the next generation of thoracic surgeons and researchers.

His dedication to bridging the gap between clinical practice and scientific discovery ensures a lasting impact on thoracic surgery and oncology worldwide.

🔑 KEYWORDS

Thoracic Surgery, Lung Cancer, Esophageal Cancer, Translational Research, AMG-510, Cisplatin, KRAS G12C Mutation, Osalmid, EGFR-TKI Sensitivity, Zhejiang Cancer Hospital, Thoracic Oncology Innovation.

📑NOTABLE PUBLICATIONS 

"The association between the cough and the inflation of esophagus" 

  • Authors: Wu, L.-L. , Xie, D.
  • Journal: Respiratory Investigation
  • Year: 2024

"Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy" 

  • Authors: Li, K. , Wu, L. , Wang, H. , Wang, J. , Xie, D.
  • Journal: Journal of Nanobiotechnology
  • Year: 2024

"The molecular characteristics could supplement the staging system of pT2/T3N0M0 esophageal squamous cell carcinoma: a translational study based on a cohort with over 20 years of follow-up" 

  • Authors: Jiang, W.-M. , Tian, J.-Y. , Guo, Y.-H. , Wu, L.-L. , Ma, G.-W.
  • Journal: Cancer Cell International
  • Year: 2024

"Longitudinal assessment of quality of life indicators and prognosis in esophageal cancer patients with curative resection" 

  • Authors: Qiu, L.-H. , Liang, S.-H. , Wu, L. , Zhong, J.-D. , Ma, G.-W.
  • Journal: Journal of Thoracic Disease
  • Year: 2024

"Antitumor effects of a Sb-rich polyoxometalate on non-small-cell lung cancer by inducing ferroptosis and apoptosis" 

  • Authors: Lin, J.-W. , Zhou, Y. , Xiao, H.-P. , Li, X.-X. , Li, Z.-X.
  • Journal: Chemical Science
  • Year: 2024